ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,930,000 | -44.3% | 3,000,000 | 0.0% | 1.78% | -39.5% |
| Q2 2023 | $28,590,000 | +86536.4% | 3,000,000 | 0.0% | 2.94% | -28.6% |
| Q1 2023 | $33,000 | -25.7% | 3,000,000 | 0.0% | 4.12% | -16.9% |
| Q4 2022 | $44,400 | -99.9% | 3,000,000 | 0.0% | 4.96% | -27.5% |
| Q3 2022 | $57,330,000 | -10.3% | 3,000,000 | 0.0% | 6.84% | -8.7% |
| Q2 2022 | $63,930,000 | -16.6% | 3,000,000 | -24.6% | 7.50% | +0.7% |
| Q1 2022 | $76,641,000 | -7.1% | 3,979,292 | 0.0% | 7.44% | +13.7% |
| Q4 2021 | $82,531,000 | -13.2% | 3,979,292 | 0.0% | 6.54% | +11.0% |
| Q3 2021 | $95,065,000 | -12.5% | 3,979,292 | 0.0% | 5.90% | -17.1% |
| Q2 2021 | $108,595,000 | -5.7% | 3,979,292 | 0.0% | 7.12% | +9.1% |
| Q1 2021 | $115,121,000 | +2.8% | 3,979,292 | 0.0% | 6.52% | -7.2% |
| Q4 2020 | $111,937,000 | -4.0% | 3,979,292 | 0.0% | 7.03% | -35.3% |
| Q3 2020 | $116,593,000 | -3.1% | 3,979,292 | 0.0% | 10.87% | -13.8% |
| Q2 2020 | $120,334,000 | +1.5% | 3,979,292 | 0.0% | 12.60% | -37.2% |
| Q1 2020 | $118,583,000 | – | 3,979,292 | – | 20.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $314,175,000 | 35.62% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $118,583,000 | 20.06% |
| Omega Fund Management, LLC | 844,680 | $25,171,000 | 10.42% |
| Vivo Capital, LLC | 1,686,527 | $50,259,000 | 4.55% |
| Orbimed Advisors | 4,673,850 | $139,281,000 | 2.34% |
| RA Capital Management | 1,165,184 | $34,722,000 | 1.10% |
| Polar Capital LLP | 375,000 | $11,175,000 | 0.12% |
| CAAS CAPITAL MANAGEMENT LP | 22,413 | $668,000 | 0.07% |
| FMR LLC | 5,713,343 | $170,258,000 | 0.02% |
| Laurion Capital Management LP | 50,000 | $1,490,000 | 0.02% |